STLN

SEC source: 0000935836-25-000416 · ownership.xml · nonDerivative · entry 2

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,501,881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000935836-25-000416 · ownership.xml · nonDerivative · entry 1

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,396,561

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-25-027205 · wk-form4_1747937561.xml · nonDerivative · entry 1

Carter Robert Ross · CIK 0002039341 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 235,174

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

SEC source: 0001628280-25-027210 · wk-form4_1747938137.xml · nonDerivative · entry 1

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,787,309

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

SEC source: 0001628280-25-027208 · wk-form4_1747937825.xml · nonDerivative · entry 1

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 234,336

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

SEC source: 0001628280-25-027201 · wk-form4_1747936763.xml · nonDerivative · entry 1

Castle Jeremy · CIK 0001992507 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 247,031

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

F2 · price: Price is the selling price of all sales by the Reporting Person on May 21, 2025. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at the certain price.

SEC source: 0000935836-25-000396 · ownership.xml · nonDerivative · entry 1

Langsam Jeffrey · CIK 0002069752 · Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,380

F1 · shares: Represents RSU awards that were fully vested upon grant, net of withholding tax obligations.

SEC source: 0001213900-25-046977 · ownership.xml · nonDerivative · entry 2

M33 Growth I L.P. · CIK 0001718621 · Director · 10% owner

M33 Growth I GP LLC · CIK 0001894303 · Director · 10% owner

TOI M, LLC · CIK 0001892968 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 1,349,048

F2 · ownership.nature: These securities are held by TOI M, LLC.

SEC source: 0001213900-25-046977 · ownership.xml · nonDerivative · entry 1

M33 Growth I L.P. · CIK 0001718621 · Director · 10% owner

M33 Growth I GP LLC · CIK 0001894303 · Director · 10% owner

TOI M, LLC · CIK 0001892968 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,624,233

F1 · ownership.direct: M33 Growth I GP LLC ("M33 LLC") is the general partner of M33 Growth I L.P. ("M33 LP") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.

SEC source: 0001799191-25-000021 · wk-form4_1743628960.xml · nonDerivative · entry 1

Carter Robert Ross · CIK 0002039341 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 236,775

F1 · shares: Represents RSU awards with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0001799191-25-000023 · wk-form4_1743631975.xml · nonDerivative · entry 1

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 236,137

F1 · shares: Represents RSU awards with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0001799191-25-000019 · wk-form4_1743628617.xml · nonDerivative · entry 1

Castle Jeremy · CIK 0001992507 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 252,667

F1 · shares: Represents RSU awards with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0001799191-25-000017 · wk-form4_1743628144.xml · nonDerivative · entry 1

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,807,697

F1 · shares: Represents RSU awards with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0001079973-25-000513 · ownership.xml · derivative · entry 2

BARASCH RICHARD A · CIK 0001076341 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LLC

Disclosed balance after: 679,224

Underlying: Common Stock · 679,224 shares

Expires 2030-03-26

F1 · security: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F1 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

F4 · derivative.exercise_date: The holder may not exercise any portion of a Common Warrant to the extent that the holder would beneficially own more than 4.99% of the number of shares of Common Stock outstanding immediately prior to or after giving effect to such exercise, as such percentage ownership is determined in accordance with Section 13(d) under the Securities Exchange Act of 1934, as amended.

F3 · ownership.nature: Securities were purchased by RAB Ventures (DFP) LLC, an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein.

SEC source: 0001079973-25-000513 · ownership.xml · nonDerivative · entry 1

BARASCH RICHARD A · CIK 0001076341 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LLC

Disclosed balance after: 1,775,641

F1 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

F3 · ownership.nature: Securities were purchased by RAB Ventures (DFP) LLC, an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein.

SEC source: 0001079973-25-000515 · ownership.xml · derivative · entry 2

Carter Robert Ross · CIK 0002039341 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,528

Underlying: Common Stock · 4,528 shares

Expires 2030-03-26

F1 · security: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F1 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · kind: The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F3 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

F4 · derivative.exercise_date: The reporting person may not exercise any portion of a Common Warrant to the extent that the reporting person would beneficially own more than 4.99% of the number of shares of Common Stock outstanding immediately prior to or after giving effect to such exercise, as such percentage ownership is determined in accordance with Section 13(d) under the Exchange Act.

SEC source: 0001079973-25-000515 · ownership.xml · nonDerivative · entry 1

Carter Robert Ross · CIK 0002039341 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,407

F1 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · kind: The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F3 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

SEC source: 0001013762-25-004330 · ownership.xml · derivative · entry 2

M33 Growth I L.P. · CIK 0001718621 · Director · 10% owner

M33 Growth I GP LLC · CIK 0001894303 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,358,449

Underlying: Common Stock · 1,358,449 shares

Expires 2030-03-26

F1 · price: On March 26, 2025, pursuant to a Securities Purchase Agreement, dated March 24, 2025, M33 Growth I LP ("M33 LP") purchased an aggregate of 1,358,449 units ("Units") consisting of 2,716,898 shares of common stock and 1,358,449 warrants ("Warrants") to purchase shares of common stock for an exercise price of $1.1980 per share. M33 acquired the Units for a price per Unit of $2.2084 (an aggregate purchase price of $2,999,998.77), with a cost per share of common stock of $1.0417 and a cost per Warrant of $0.1250. The Warrants are not exercisable to the extent that the exercise thereof would cause the reporting person to beneficially own greater than 19.99% of the outstanding shares of common stock of the Issuer. The purchase of the Units was approved by the Issuer's Board of Directors in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

F2 · ownership.direct: M33 Growth I GP LLC ("M33 LLC") is the general partner of M33 LP ("M33 GP") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.

SEC source: 0001013762-25-004330 · ownership.xml · nonDerivative · entry 1

M33 Growth I L.P. · CIK 0001718621 · Director · 10% owner

M33 Growth I GP LLC · CIK 0001894303 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,420,701

F1 · price: On March 26, 2025, pursuant to a Securities Purchase Agreement, dated March 24, 2025, M33 Growth I LP ("M33 LP") purchased an aggregate of 1,358,449 units ("Units") consisting of 2,716,898 shares of common stock and 1,358,449 warrants ("Warrants") to purchase shares of common stock for an exercise price of $1.1980 per share. M33 acquired the Units for a price per Unit of $2.2084 (an aggregate purchase price of $2,999,998.77), with a cost per share of common stock of $1.0417 and a cost per Warrant of $0.1250. The Warrants are not exercisable to the extent that the exercise thereof would cause the reporting person to beneficially own greater than 19.99% of the outstanding shares of common stock of the Issuer. The purchase of the Units was approved by the Issuer's Board of Directors in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

F2 · ownership.direct: M33 Growth I GP LLC ("M33 LLC") is the general partner of M33 LP ("M33 GP") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.

SEC source: 0001079973-25-000529 · ownership.xml · derivative · entry 2

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,320

Underlying: Common Stock · 11,320 shares

Expires 2030-03-26

F1 · security: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F1 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · kind: The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F3 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

F4 · derivative.exercise_date: The reporting person may not exercise any portion of a Common Warrant to the extent that the reporting person would beneficially own more than 9.99% of the number of shares of Common Stock outstanding immediately prior to or after giving effect to such exercise, as such percentage ownership is determined in accordance with Section 13(d) under the Exchange Act.

SEC source: 0001079973-25-000529 · ownership.xml · nonDerivative · entry 1

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 724,363

F1 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · kind: The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F3 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

SEC source: 0001079973-25-000527 · ownership.xml · derivative · entry 2

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,528

Underlying: Common Stock · 4,528 shares

Expires 2030-03-26

F1 · security: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F1 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · kind: The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F3 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

F4 · derivative.exercise_date: The reporting person may not exercise any portion of a Common Warrant to the extent that the reporting person would beneficially own more than 4.99% of the number of shares of Common Stock outstanding immediately prior to or after giving effect to such exercise, as such percentage ownership is determined in accordance with Section 13(d) under the Exchange Act.

SEC source: 0001079973-25-000527 · ownership.xml · nonDerivative · entry 1

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,049

F1 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · kind: The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F3 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

SEC source: 0001079973-25-000525 · ownership.xml · derivative · entry 2

Pacala Mark L · CIK 0001321250 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LLC

Disclosed balance after: 42,281

Underlying: Common Stock · 42,281 shares

Expires 2030-03-26

F1 · security: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F1 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

F4 · derivative.exercise_date: The holder may not exercise any portion of a Common Warrant to the extent that the holder would beneficially own more than 4.99% of the number of shares of Common Stock outstanding immediately prior to or after giving effect to such exercise, as such percentage ownership is determined in accordance with Section 13(d) under the Securities Exchange Act of 1934, as amended.

F3 · ownership.nature: Securities were purchased by Pacala Enterprises, LLC, an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein.

SEC source: 0001079973-25-000525 · ownership.xml · nonDerivative · entry 1

Pacala Mark L · CIK 0001321250 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LLC

Disclosed balance after: 224,971

F1 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

F3 · ownership.nature: Securities were purchased by Pacala Enterprises, LLC, an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein.

SEC source: 0001079973-25-000523 · ownership.xml · derivative · entry 2

Johnson Karen Marie · CIK 0001892819 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,112

Underlying: Common Stock · 18,112 shares

Expires 2030-03-26

F1 · security: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F1 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · kind: The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F3 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

F4 · derivative.exercise_date: The reporting person may not exercise any portion of a Common Warrant to the extent that the reporting person would beneficially own more than 4.99% of the number of shares of Common Stock outstanding immediately prior to or after giving effect to such exercise, as such percentage ownership is determined in accordance with Section 13(d) under the Exchange Act.

SEC source: 0001079973-25-000523 · ownership.xml · nonDerivative · entry 1

Johnson Karen Marie · CIK 0001892819 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 203,409

F1 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · kind: The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F3 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

SEC source: 0001079973-25-000521 · ownership.xml · derivative · entry 2

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,528

Underlying: Common Stock · 4,528 shares

Expires 2030-03-26

F1 · security: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F1 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · kind: The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F3 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

F4 · derivative.exercise_date: The reporting person may not exercise any portion of a Common Warrant to the extent that the reporting person would beneficially own more than 4.99% of the number of shares of Common Stock outstanding immediately prior to or after giving effect to such exercise, as such percentage ownership is determined in accordance with Section 13(d) under the Exchange Act.

SEC source: 0001079973-25-000521 · ownership.xml · nonDerivative · entry 1

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 675,809

F1 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · kind: The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F3 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

SEC source: 0001079973-25-000519 · ownership.xml · derivative · entry 2

Castle Jeremy · CIK 0001992507 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,528

Underlying: Common Stock · 4,528 shares

Expires 2030-03-26

F1 · security: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F1 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · kind: The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F3 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

F4 · derivative.exercise_date: The reporting person may not exercise any portion of a Common Warrant to the extent that the reporting person would beneficially own more than 4.99% of the number of shares of Common Stock outstanding immediately prior to or after giving effect to such exercise, as such percentage ownership is determined in accordance with Section 13(d) under the Exchange Act.

SEC source: 0001079973-25-000519 · ownership.xml · nonDerivative · entry 1

Castle Jeremy · CIK 0001992507 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,386

F1 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · kind: The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F3 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

SEC source: 0000935836-25-000296 · ownership.xml · derivative · entry 2

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,640

Underlying: Common Stock · 22,640 shares

Expires 2030-03-26

F2 · security: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F2 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F3 · kind: The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F1 · shares: This amendment is filed to correct the number of shares of Common Stock and number of Common Warrants acquired by the reporting person in the transaction reported on the original Form 4 filed on March 28, 2025. As a result of this correction, the amount of securities beneficially owned following the reported transaction specified in Table I, Column 5 and Table II, Column 9 have also been corrected.

F4 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

F5 · derivative.exercise_date: The reporting person may not exercise any portion of a Common Warrant to the extent that the reporting person would beneficially own more than 4.99% of the number of shares of Common Stock outstanding immediately prior to or after giving effect to such exercise, as such percentage ownership is determined in accordance with Section 13(d) under the Exchange Act.

F1 · derivative.underlying_shares: This amendment is filed to correct the number of shares of Common Stock and number of Common Warrants acquired by the reporting person in the transaction reported on the original Form 4 filed on March 28, 2025. As a result of this correction, the amount of securities beneficially owned following the reported transaction specified in Table I, Column 5 and Table II, Column 9 have also been corrected.

SEC source: 0000935836-25-000296 · ownership.xml · nonDerivative · entry 1

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 712,033

F2 · kind: Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").

F3 · kind: The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F1 · shares: This amendment is filed to correct the number of shares of Common Stock and number of Common Warrants acquired by the reporting person in the transaction reported on the original Form 4 filed on March 28, 2025. As a result of this correction, the amount of securities beneficially owned following the reported transaction specified in Table I, Column 5 and Table II, Column 9 have also been corrected.

F4 · price: Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.

SEC source: 0001799191-25-000006 · wk-form4_1742507796.xml · nonDerivative · entry 1

Carter Robert Ross · CIK 0002039341 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,351

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

SEC source: 0001799191-25-000008 · wk-form4_1742508091.xml · nonDerivative · entry 1

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 701,723

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

SEC source: 0001799191-25-000007 · wk-form4_1742507899.xml · nonDerivative · entry 1

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,993

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

SEC source: 0001799191-25-000002 · wk-form4_1736273886.xml · nonDerivative · entry 1

Carter Robert Ross · CIK 0002039341 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,501

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on January 6, 2025 within a one-dollar range. Actual prices ranged from $0.293 to $0.335. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

SEC source: 0001799191-24-000065 · wk-form4_1733432530.xml · nonDerivative · entry 1

Castle Jeremy · CIK 0001992507 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,330

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on December 3, 2024 within a one-dollar range. Actual prices ranged from $0.156 to $0.160. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

SEC source: 0001799191-24-000063 · wk-form4_1733173486.xml · nonDerivative · entry 3

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 666,753

F2 · balance_after: 44,000 being restricted stock units that vest in full on the date of the Company's 2025 annual meeting of stockholders, subject to continued service with the Company through such vesting date.

SEC source: 0001799191-24-000063 · wk-form4_1733173486.xml · nonDerivative · entry 2

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 616,753

F2 · balance_after: 44,000 being restricted stock units that vest in full on the date of the Company's 2025 annual meeting of stockholders, subject to continued service with the Company through such vesting date.

SEC source: 0001799191-24-000061 · wk-form4_1732570700.xml · nonDerivative · entry 1

BARASCH RICHARD A · CIK 0001076341 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 417,193

F1 · shares: Represents restricted stock units that vest in full on TOI, Inc.'s 2025 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

SEC source: 0001799191-24-000052 · wk-form4_1732569631.xml · nonDerivative · entry 1

Ling Gabriel · CIK 0001945281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,057

F1 · shares: Represents restricted stock units that vest in full on TOI, Inc.'s 2025 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

SEC source: 0001799191-24-000059 · wk-form4_1732570323.xml · nonDerivative · entry 1

Pacala Mark L · CIK 0001321250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,409

F1 · shares: Represents restricted stock units that vest in full on TOI, Inc.'s 2025 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

SEC source: 0001799191-24-000057 · wk-form4_1732570125.xml · nonDerivative · entry 1

McGeorge Anne · CIK 0001779934 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,346

F1 · shares: Represents restricted stock units that vest in full on TOI, Inc.'s 2025 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

SEC source: 0001799191-24-000055 · wk-form4_1732569990.xml · nonDerivative · entry 1

Johnson Karen Marie · CIK 0001892819 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 167,185

F1 · shares: Represents restricted stock units that vest in full on TOI, Inc.'s 2025 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

SEC source: 0001799191-24-000053 · wk-form4_1732569806.xml · nonDerivative · entry 1

Kaushal Mohit · CIK 0001683021 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,253

F1 · shares: Represents restricted stock units that vest in full on TOI, Inc.'s 2025 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

SEC source: 0001799191-24-000050 · wk-form4_1732569282.xml · nonDerivative · entry 1

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 720,203

F1 · shares: Represents restricted stock units that vest in full on TOI, Inc.'s 2025 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

SEC source: 0001799191-24-000042 · wk-form4_1732231303.xml · nonDerivative · entry 1

Carter Robert Ross · CIK 0002039341 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,759

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on November 20, 2024 within a one-dollar range. Actual prices ranged from $0.136 to $0.168. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

SEC source: 0001799191-24-000043 · wk-form4_1732231374.xml · nonDerivative · entry 2

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 711,984

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on November 20, 2024 within a one-dollar range. Actual prices ranged from $0.136 to $0.168. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

SEC source: 0001799191-24-000043 · wk-form4_1732231374.xml · nonDerivative · entry 1

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 716,961

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on November 20, 2024 within a one-dollar range. Actual prices ranged from $0.136 to $0.168. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.